Pathophysiology · MU Sofia

51. Hyperparathyroidism - classification, etiology, pathogenesis, clinical manifestations.

Inside: 1 section · 1 table · 15 flashcards · 2 min

Topic 51 of 168 in the MU Sofia syllabus for Pathophysiology (Medicine, Year 3). The free AceMed note covers it in 1 section, about 299 words (2 min of reading), with 15 flashcards.

In this note

  1. Hyperparathyroidism - classification, etiology, pathogenesis, and clinical manifestations

Hyperparathyroidism - classification, etiology, pathogenesis, and clinical manifestations

Hyperparathyroidism is a condition of excessive secretion of parathyroid hormone (PTH), leading to hypercalcemia and hypophosphatemia, with effects on bone, kidney, and other organs.

Classification

  1. 1 Primary hyperparathyroidism
  • Problem in the parathyroid gland itself.
  1. 2 Secondary hyperparathyroidism
  • Chronic hypocalcemia (external cause) → compensatory increase in PTH.
  1. 3 Tertiary hyperparathyroidism
  • Long-standing secondary hyperparathyroidism → autonomous PTH secretion even after correction of hypocalcemia.

Etiology

  • Primary hyperparathyroidism
  • Parathyroid adenoma (most common cause, ~85%).
  • Parathyroid hyperplasia (e.g., in multiple endocrine neoplasia syndromes MEN 1 and MEN 2A).
  • Parathyroid carcinoma (rare).
  • Secondary hyperparathyroidism
  • Chronic renal failure (most common cause): phosphate retention and decreased vitamin D activation → hypocalcemia → ↑ PTH.
  • Vitamin D deficiency (dietary or lack of sun exposure).
  • Malabsorption syndromes.
  • Tertiary hyperparathyroidism
  • Usually in patients with chronic renal failure after prolonged secondary hyperparathyroidism.

Pathogenesis

Primary hyperparathyroidism

  1. Autonomous overproduction of PTH from adenoma or hyperplasia.
  2. Increased osteoclastic bone resorption → release of calcium and phosphate.
  3. Increased renal tubular calcium reabsorption, phosphate excretion → hypercalcemia, hypophosphatemia.
  4. Increased conversion of vitamin D to active form → increased intestinal calcium absorption.

Secondary hyperparathyroidism

  1. Chronic hypocalcemia stimulates parathyroid glands → diffuse hyperplasia.
  2. Persistent stimulation → excessive PTH production.

Tertiary hyperparathyroidism

  1. After long-standing secondary hyperparathyroidism, glands become autonomous.
  2. Secrete PTH irrespective of calcium level → hypercalcemia.

Clinical manifestations

Due to hypercalcemia ("stones, bones, groans, and psychic moans")

  • Stones: kidney stones (nephrolithiasis).
  • Bones: bone pain, fractures, osteitis fibrosa cystica (bone lesions with fibrous replacement and cysts).
  • Groans: gastrointestinal symptoms — nausea, vomiting, constipation, peptic ulcers, pancreatitis.
  • Psychic moans: neuropsychiatric symptoms — weakness, fatigue, depression, confusion.

Other features

  • Polyuria and polydipsia (nephrogenic diabetes insipidus due to hypercalcemia-induced renal concentrating defect).
  • Muscle weakness.
  • Hypertension (some cases).

In secondary hyperparathyroidism

  • Bone changes (renal osteodystrophy): subperiosteal bone resorption, bone pain.
  • Usually no hypercalcemia; patients often have low or normal calcium levels.

Summary Table

Read the full note free

The whole note is free with an AceMed account, with its 15 flashcards. Premium adds flashcard recall, highlights and Ask AI.